Met Inhibitors
Santa Cruz Biotechnology now offers a broad range of Met Inhibitors. MET (c-Met) is a proto-oncogene that encodes a protein known as hepatocyte growth factor receptor (HGFR). MET is a membrane receptor that is essential for embryonic development and wound healing. Cancer stem cells are thought to adopt the ability to express MET, and thus become the cause of cancer persistence. Met Inhibitors offered by Santa Cruz inhibit Met and, in some cases, other hepatocyte growth factor and tumor growth related proteins. View detailed Met Inhibitor specifications, including Met Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
Items 1 to 10 of 22 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PHA 665752 | 477575-56-7 | sc-203186 sc-203186A sc-203186B sc-203186C | 2 mg 10 mg 50 mg 200 mg | $140.00 $275.00 $700.00 $1480.00 | 24 | |
PHA 665752 (CAS 477575-56-7) is a chemical compound known for its role as a potent inhibitor of Met. It modulates Met activity, impacting cellular processes. The compound's effects on Met signaling have garnered attention in research and exploration due to its potential implications in various contexts. | ||||||
BMS 777607 | 1025720-94-8 | sc-364438 sc-364438A | 10 mg 50 mg | $392.00 $1244.00 | 1 | |
BMS 777607 (CAS 1025720-94-8) is a chemical compound known for its role as a Met inhibitor. It effectively modulates Met activity, impacting relevant processes. | ||||||
VEGFR2 Kinase Inhibitor III | 204005-46-9 | sc-202851 | 5 mg | $162.00 | 7 | |
VEGFR2 Kinase Inhibitor III, with CAS number 204005-46-9, functions as a Met inhibitor, impacting cellular processes. It modulates Met activity, potentially influencing relevant pathways. | ||||||
Met Kinase Inhibitor | 658084-23-2 | sc-204801 | 1 mg | $116.00 | 5 | |
SU11274 hinders MET phosphorylation, suppressing tumor cell proliferation and metastasis. | ||||||
Foretinib | 849217-64-7 | sc-364492 | 5 mg | $129.00 | 6 | |
Foretinib inhibits MET and VEGFR2, interfering with MET-mediated cell proliferation and angiogenesis. | ||||||
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $126.00 $210.00 $488.00 | 19 | |
K-252a (CAS 99533-80-9) is a chemical compound known for its role as an inhibitor of Met, a significant signaling protein. It impacts Met-related processes without indication of clinical application. | ||||||
RPI-1 | 269730-03-2 | sc-255524 sc-255524A | 5 mg 10 mg | $153.00 $186.00 | 4 | |
RPI-1 (CAS 269730-03-2) is a chemical compound recognized for its role as a Met inhibitor, influencing Met-related processes. It has demonstrated effects on cellular functions without delving into clinical applications. | ||||||
XL-184 free base | 849217-68-1 | sc-364657 sc-364657A | 5 mg 10 mg | $92.00 $204.00 | 1 | |
XL-184 free base is a multi-kinase inhibitor that targets MET and VEGFR2. It prevents MET autophosphorylation, blocking cell growth and angiogenesis in cancer. | ||||||
Sodium succinate dibasic | 150-90-3 | sc-251053 | 100 g | $39.00 | ||
Sodium succinate dibasic exhibits intriguing properties as a dibasic acid, characterized by its capacity to engage in multiple protonation states. This compound demonstrates unique buffering capabilities, maintaining pH stability in various conditions. Its ionic nature enhances solubility in aqueous environments, promoting effective ion pairing and interaction with other charged species. Additionally, its role in metabolic pathways highlights its significance in energy transfer and cellular processes, making it a compound of interest in biochemical studies. | ||||||
AMG-208 | 1002304-34-8 | sc-364399 sc-364399A | 10 mg 50 mg | $645.00 $1950.00 | ||
AMG 208 is a potent MET inhibitor that interrupts MET signaling, hindering cancer cell growth and survival. | ||||||